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Abigail Repor-Tastory5 , Discovery Presenter, turns to
face the camera:
Good evening viewers and welcome to a new episode of
‘Discoveries that Change our Lives’. Our guest this eve-
ning is once again Dr. Anastasia Noitall-Most5 from the
Streber Elite University of Los Angeles.5 Good evening
Dr. Noitall-Most (shaking hands) and thank you for
appearing on the program.
Dr. Noitall-Most : Good evening Abi; it is always a plea-
sure to be here.
Ms. Repor-Tastory : Ani, this evening we will continue to
explore the subject of the last episode, namely the most
ambitious human microbiome survey to date, the Global
Phenotype-Genotype Survey, or GLOPS.6
Dr. Noitall-Most : Yes: we already knew that our micro-
biomes seem to influence several health-related aspects
of our biology, but the magnitude and range of human
characteristics suggested by the survey to be influenced
by the microbiome is just mind boggling. And now, one
year later, we have the results of the trials carried out to
test the predictions of the correlations found in the sur-
vey. The trials indeed established a number of really
interesting human characteristics that are significantly
influenced by our microbiome. A taste of this was given
in the previous programme when I revealed that a new
type of bacterium found in the oral cavity seems to influ-
ence diction.6
Ms. Repor-Tastory : Yes, Ani, that was absolutely amaz-
ing: please tell us more.
Dr. Noitall-Most : Right! This evening I should like to
share with viewers new information on the influence of
laryngeal microbes on vocal quality.
Firstly, as we know, smokers tend to have gravelly
voices and habitually enjoy a recreational, somewhat
phlegmy cough-athon after emerging from their slumber.
This comforting, clearing-of-the-throat ritual was previ-
ously thought to be due to smoke-provoked irritation and
inflammation of the larynx, and overnight accumulation
of laryngeal mucous, but GLOPS and subsequent trials
based on its findings have consigned this theory to the
bin. Metagenome analysis revealed that smokers, but
not non-smokers, have a particular bacterium in their
laryngeal microbiota. This finding induced the Imaging
Group of Mabriella Golinari and Ranfredy Mohde of the
Walpur Gisnacht Institute for Cellular Pathology in Bad
Hurzbarg in Northern Germany,7 which was responsible
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for microbe isolation and characterization in GLOPS, to
attempt to culture and characterise this bug.
Mab and Ran initially had no success using normal iso-
lation media, but subsequently were able to tease it to
grow on a special medium containing nicotine. It subse-
quently transpired that this microbe is nicotine-depen-
dent – yes, really: nicotine-addicted! – and able to
degrade and use nicotine as a food source.8 They
named it Seudomonas nicotinadicta, which was immedi-
ately re-named Snica by young smokers. Mab and Ran
showed that Snica is distributed throughout the buccal
cavity of smokers and is particularly dense on vocal
chords.
Ms. Repor-Tastory : Gosh: imagine eating nicotine!
Dr. Noitall-Most : True – it does not bear thinking about!
But of course microbes do not necessarily share our
culinary tastes and, in reality, collectively they will eat
most anything.
Nevertheless, nicotine is toxic for most bacteria,9 as
indeed it is to most types of cell, which is why it is so
bad for our health.10 Apparently, smoking toxicity pro-
duces changes in the laryngeal microbial community,11
which becomes dominated by Snica. Snica continuously
degrades and removes nicotine from the oral mucosa,
and thereby reduces the exposure of other mucosal
microbes to nicotine toxicity – a sort of bioprotection
service12 it provides to the oral microbiota. Snica is
also resistant to the toxic effects of nicotine, partly due
to metabolic and oxidative stress responses,13 and
partly due to smoke-induction of the biofilm mode of
growth,13 which is the hunker-down mechanism
microbes adopt when challenged by toxic insults,13
such as antibiotics and immune defences, that enables
them to avoid and resist antimicrobial activities. But, for
the discussion this evening about oral microbiota and
vocal quality, a key thing about Snica is that it is a pro-
lific slime producer.14,15
During the day, this slime is unconsciously swallowed,
so is not noticeable, but during sleep it accumulates
and ultimately triggers the resonant fruity bout of
wake-up-to-the-joys-of Spring coughing that greets the
smoker’s daybreak. Importantly for our discussion
today, the continual slime production also has the
effect of changing the resonance of the vocal chords,
such that the sound output has the gravelly timbre typ-
ical of the smoker.
Ms. Repor-Tastory : Well, that is an eye-opener: so a
slimy bug in the throat is at the bottom of the deep
voice!
Dr. Noitall-Most : So it would seem. Anyway, staying on
the subject of vocal harshness: whereas this is mostly
a characteristic of smokers, it is also found in non-smo-
kers and can be either inherited from a gruffy-voiced
parent, or acquired, for example through perpetual
shouting, as evidenced by non-smoking sergeant
majors with typical parade ground timbres. In fact,
GLOPS did suggest the presence of a non-Snica-type
bacterium in the buccal cavity of non-smokers with
harsh voices that was lacking in those blessed with
mellow voices. Encouraged by their success with Snica,
Mab and Ran wanted to complete their analysis of
microbial involvement in vocal harshness and were,
with some difficulty, able to isolate this bug. They
named it Grufficus cockeri, which was immediately re-
christened Gruffy by the music industry, and showed it
to inhabit principally the surface of the epiglottis and, in
some cases, also the vocal chords. It is present in
large numbers in people with harsh voices and low
numbers in those with euphonius voices. Its very obvi-
ous characteristic is that it forms macrofibres: when
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Gruffy is growing, newly-formed cells do not separate
but remain attached to one another, forming a long
chain which, in time, repeatedly folds back on itself. As
cells continue to grow and form daughters, the force
generated causes the filament to twist and form a so-
called macrofibre.16
Mab and Ran suggest that Gruffy macrofibres create a
net-like structure that acts like a dishcloth in the voice
box, collecting all manner of flotsam floating and flying
around the buccal cavity, and thereby distorting the
sounds emanating through the vocal chords, much like
the electronic distortion of guitar notes produced by fuzz
pedals17 and the like.
Ms. Repor-Tastory : Well, on thinking about it, my throat
also feels as if it contains a dishcloth, the morning after
a long night of clubbing.
Dr. Noitall-Most : Yes, but that is something different and
probably your state of dehydration after excessive alco-
hol consumption.
Anyway, to continue: a limited trial funded by a well-known
music label involved the daily breakfast consumption of
yoghurt containing G. cockeri by country singers with dul-
cet voices who were desperate to acquire gravelly voices
so that they could sing their preferred music – hard rock or
heavy metal – without needing to develop a smoking
habit. In almost all cases, within one week, they were sing-
ing raucously like Joe Cocker18 or Janis Joplin.19
Ms. Repor-Tastory, amused enlightenment slowly spread-
ing across her face : Oohhh, this explains the sharp deep-
ening of my voice after a wild fling in Nashville with a
hunky, husky bluegrass banjo player that took
ages. . .... . .. . .(angry noises emanating from the in-ear
headphone). . .Oh, sorry, I did not mean to interrupt. . .
Dr. Noitall-Most : Yes, wild flings can be followed by all
sorts of surprises, not only deliveries of red roses.
Ms. Repor-Tastory, thoughtfully : Hhmmm. . .
Dr. Noitall-Most : But while the transfer of oral bugs
between consenting adults is one thing, the unknown
and perhaps unwanted transfer of such bugs is another.
You will recall that a major focus of GLOPS was the
transfer of microbiota among people and the phenotypic
consequences of this? Well, one aspect of this related to
tonight’s topic was an assessment of the transfer of air-
way microbiota by pillows among travellers. You know
the situation: those of us who sleep on our fronts or
sides breathe, cough, sneeze and dribble into our hotel
pillows for 8-h stretches, vigorously propelling our air-
way-oral bounties into their depths. Now while the pillow-
cases are regularly laundered and changed for every
new guest, the pillows generally are not. And, those of
us who sleep on our fronts or sides not only blow our
stuff into pillows, we also inhale and, in the case of pil-
lows used by others, inhale their stuff. Previously, it was
thought that the post-travel respiratory issues we not
infrequently experience were due to the drying out of the
airway mucosa in low humidity aeroplane cabins or to
infections gifted by other travellers in confined spaces,
like elevators. But now we know that hotel pillows can
also be a rich source of diverse microbes that enrich our
airway microbiota, sometimes with unexpected, some-
times unwanted, results.
Ms. Repor-Tastory : Hhmmm! So: sleeping on our backs,
or taking our own favourite pillow, populated with our
own microbiota, to enjoy slumber comfort on our travels,
also has the benefit of protecting our oral microbiota
from invasion by those of others? I think I’ll take my own
pillow next time I am on the road!
Oh, by the way, do microbes have anything to do with
boys’ voices breaking in puberty?
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Dr. Noitall-Most : Aahhh, that is a fascinating question,
but we will leave it for another episode dealing with the
Y-chromosome-specific microbiota. However, voice
breaking is most dramatic when singing, and the survey
did make a remarkable discovery about oral microbiota
and singing voice purity. Although the samples in the
stratification were small, there did seem to be a clear
relationship between the presence of a new laryngeal
bacterium and voice purity in professional singers, partic-
ularly opera singers. This bacterium was readily isolated
by Mab and Ran from the buccal cavities of several
stars, the identities of which have not been revealed, in
anticipation of future commercialisation of this bug and
the creation of new brands based on the names of
famous singers. Amazingly, when cells of this bacterium
were added to vocal chords excised from fresh cadav-
ers, they bound tightly and spontaneously reorganised
themselves in such a way that they increased the ten-
sion in and caused contraction of the chords. This was
slightly disconcerting for Mab and Ran looking down
the microscope at this happening in real time, given that
the chords were nominally dead! The bug was given the
name Harmonicoccus sublimiae.20
Ms. Repor-Tastory : Gosh! Does Harmoniwhatshername-
containing yoghurt improve singing voices? Most Fri-
days, a close girlfriend and I, both dressed to kill, go to
a rather upmarket karaoke bar and it would be nice to
have a bit of an edge over the competition. . ..
Dr. Noitall-Most : That is of course a key question, but
the trial has not yet been concluded.
Ms. Repor-Tastory : Hmm – I’ll have to get from you the
coordinates of the trial leader during our post-transmis-
sion margarita.
Dr. Noitall-Most : Certainly. Another rather curious finding
was that, rather unexpectedly, individuals involved in the
business of persuasion – spin doctors, politicians,
lobbyists, ad(wo)men, salespersons – especially those
selling automobiles and real estate, industry consultants,
fundraisers, gurus of all types, but especially lifestyle
and diet gurus, vloggers,21 and celebrity chefs, tend to
have a somewhat atypical tongue microbiota containing
significant numbers of a bacterium that was extremely
difficult to isolate in pure culture, though it grew happily
in a mixed culture containing other microbes from the
buccal cavity. However, the highly experienced German
pair finally obtained two isolates by extinction dilution in
a rich medium containing traces of silver nitrate. When
they characterised the bugs, they found that they have
an exceptionally high affinity for silver ions in food and
drink consumed,22 which they convert to cell-bound sil-
ver nanoparticles,23 giving the tongue a slightly silvery
appearance. They named them Silvertonguium guruis, or
Silg, and S. uberdentischzieha, or Sudz.24
Curious to know if Silg and Sudz transplantation could
improve the rhetorical ability of recipients, a small trial
was carried out, but it was quickly aborted when it
became apparent that Silg and Sudz failed to colonize
and survive on the tongues of most donors.
Ms. Repor-Tastory : So, the adage that people with the
power of persuasion have silver tongues is true after all!
But why don’t transplants of Silg and Sudz work?
Dr. Noitall-Most : Well, the explanation offered by the trial
consultant, Professor Tim Kennis of the Queenton Insti-
tute of Advanced Studies is that exceptional rhetorical
ability in certain individuals25 appears to have a genetic
component that predetermines not only development of
oratorical skills but also predisposes such individuals to
lifestyles involving persuading other members of society.
He considers it to be entirely plausible that this genetic
trait simultaneously modifies normal tongue physiology
such that it creates an attractive environment for Silg
and Sudz. To explore this possibility, he carried out a
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small study on buccal fluids from Sudz-positive and -
negative individuals and found that Sudz grew happily in
fluid from Sudz-positive individuals but hardly at all in
fluid from Sudz-negative individuals, which supports the
view that the tongue physiology of persuaders is differ-
ent from that normal folk. He has carried out bioinfor-
matic analyses of the genomes of Sudz and its
relatives and has shown that, in terms of human evolu-
tion, silver nanoparticle production by Sudz and its pre-
decessors is a relatively ancient trait, but that it is only
found in human-colonising strains, not in animal-colonis-
ing relatives. He suggests that humans have always
valued the ability to persuade and direct the views of
their fellow men and women, and that the genetic trait
that favours this ability has co-evolved with Silg/Sudz
ancestors over time to increase the efficacy of this abil-
ity. He suspects that if we could sample the tongues of
the great orators,25 like Aristotle, Cicero, Henry V, etc.,
we would be able to see this co-evolution of the human
and Silg/Sudz ancestral genomes leading to current
rhetorical abilities.
Ms. Repor-Tastory : Hmm – so our silver tongue-based
rhetorical genealogies have a silver thread!
Ok, so finally, let me come to my traditional closing
question: are there any applications of this part of the
GLOPS investigation?
Dr. Noitall-Most : Yes, of course, Abi! Unexpectedly,
there is not inconsiderable interest in Gruffy-like macrofi-
bre producers for modulating vocal qualities. There is for
example a significant, but previously unrecognised
demand from people in the military, law enforcement
agencies, team sport training, and the like – both
squeaky-voiced males and mellow-voiced females – who
have all the necessary qualities for rapid advancement
in these careers, but do not feel that they have the requi-
site harsh voice tone and throw needed on the parade
ground, rioting streets, football field, etc.
Ms. Repor-Tastory, with a wicked look : How strange! I
have always had a rather melodic voice and when I was
a cheerleader of the SCU5 Football team, I never had
any problems getting the attention of the team.
Dr. Noitall-Most : Yeeeess, well. In addition to this niche
market, there are a range of more general applications.
First and foremost, nicotine-degrading bacteria and the
enzymes of their catabolic pathways are being used in a
variety of ways. These include the use of pathway
enzymes for biocatalysis – the use of enzymes to carry
out chemical reactions – green chemistry that is environ-
mentally and energetically friendly,26 and in the removal
of nicotine in tobacco processing wastes,27 which can
cause environment pollution.
But perhaps most interesting to viewers are the health
applications of this work.
As I mentioned earlier, smoking results in significant
changes in the buccal flora.12 Well, it turns out that it
also has an impact on the composition and metabolic
activities of the gut microbiota.28 Whether or not these
changes constitute dysbioses of airway and/or gut micro-
biota and, if so, whether or not they contribute to smok-
ing-related diseases, is not presently known but is the
subject of increasingly active research. For example,
smokers have a greater susceptibility to respiratory infec-
tions.29 While this may well be due to smoke-caused
weakened resilience of the airway epithelium and associ-
ated immune defences,29 it may instead or additionally
be due to the functional consequences of airway micro-
biota dysbiosis.
And, given the physical and functional connectivity of the
airway and alimentary microbiota, and the association of
a number of health issues with gut microbiota dysbioses,
it might well be that some of the other health prejudicial
consequences of smoking result from air/gut microbiota
dysbioses it causes. Thus, one type of investigation cur-
rently underway by new microbiome enterprises, and
especially global food companies, which are increasingly
interested in the new prophylaxis and therapy opportuni-
ties offered by functional foods, is to determine whether
or not transplants of healthy oral microbiota might reduce
smoking-associated diseases and, if so, which ones.
Ms. Repor-Tastory : Don’t you find it amazing, and some-
what confusing, how blurred the business focus of many
large companies has become in recent years? A food
company used to satisfy our nutritional requirements, a
phone company used to enable us communicate remo-
tely with one another, an informatics company used to
help us get on the digital highway, but now their activi-
ties are all mixed up – they would probably say strategi-
cally integrated – and one way or another are all in the
health or entertainment businesses.
Dr. Noitall-Most : Absolutely true Abi: the world is indeed
changing.
Another topic receiving intense attention is nicotine
addiction30 which, as viewers may know, is the leading
cause of preventable disease and premature death.11 Its
biological basis, involving inter alia the so-called dopa-
mine reward pathway, is now well defined but so far
attempts to find ways and means of aiding smokers to
kick the habit have not yielded the desired outcome.30 As
a result of GLOPS, the Lorenzo von Syntech High Secu-
rity Institute for Artificial Life in Madrid, headed by the
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world-renowned Professor Vic Torde, recently embarked
on an ambitious synthetic microbiology programme to
design an excellent throat colonising bacterium that will
smooth the withdrawal process for those who finally
decide that it is high time to quit. This bug, tentatively
named by Vic Nicowithdrawia facilensis, will contain the
following: (i) a highly efficient nicotine degradation path-
way to reduce the amount of nicotine entering the lungs
during puffing activity, which is intended to have the dual
benefit of reducing nicotine-related tissue damage and of
gently weaning smokers off their addiction,31 (ii) a new
metabolic route for high level production of vitamin C, to
compensate for the increased need for vitamin C in
smokers,32 and (iii) novel biosynthetic pathways for the
production of 2 neuroactive compounds that counteract
the nicotine withdrawal symptoms of irritability, depressed
mood, hedonic dysregulation, restlessness, anxiety, con-
centration difficulty, increased hunger, insomnia and
tobacco craving3233. Experiments with some of the initial
constructs given to addicted mice look promising, so
smokers may soon have a golden bullet at their disposal.
Ms. Repor-Tastory : Well, I never: smoking mice!
Dr. Noitall-Most : Vic is also very interested in the nanosil-
ver production activities of Silg and Sudz because nanosil-
ver has an amazing spectrum of applications in industry,
food manufacture, medicine and consumer products2334.
An important property of silver nanoparticles is their pow-
erful antimicrobial activity, which is exploited in disinfec-
tants, decontamination, air purification, and the coating of
medical devices, like catheters, to prevent their colonisa-
tion by microbes, especially pathogens, and for impregna-
tion of clinical clothing. Nanosilver is also used to improve
diagnostic imaging and is showing promise as an enhanc-
ing agent in cancer therapies. Though he will not be very
specific at this stage, Professor Torde is designing deriva-
tives of Silg that not only produce silver nanoparticles at
much greater efficiencies than natural microbes, but also
derivatives that produce functionalised nanoparticles, that
is, silver particles coated with molecules, including
nanobodies – designed single chain camel antibiodies,35
that endow them with high affinities for a diverse range of
targets for the purpose of detection, measurement and, in
some cases further metabolism or harvesting. I am sure
we will learn of some very interesting advances from Vic
in the near future.
And while on the topic of Silg and Sudz, an amazing
number of people now routinely have their microbiomes
sampled and composition determined, not only to
upstage their friends at cocktail parties and on social
media, but also to learn about their health-related
genetic profiles. Interestingly, a not insignificant number
of people have discovered that they have Silg or Sudz
residing in their buccal mucosa. And not an insignificant
number of such individuals pay genome companies
small fortunes to carry out genealogy investigations to
assess whether they might be descendants of one or
other of the great Greek or Roman orators. Most of
these do it out of curiosity, but others, especially bud-
ding spin doctors, politicians, sales personnel and lob-
byists, do it in order to enhance their CVs with tenuous
documentation of credentials and pedigrees of their per-
suasive abilities.
Ms. Repor-Tastory : well, viewers: on that rhetorical note,
we end this edition of ‘Discoveries that Change our
Lives’. We will be back next week with a follow-up edi-
tion to reveal some more of the amazing findings of
GLOPS and its experimental follow-up.
As the camera pulls away, viewers see Abi leaning
towards Ani and hear her saying : to get back to my kar-
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